Cargando…
Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study
MicroRNAs (miRs) have emerged as biomarkers of migraine disease in both adults and children. In this study we evaluated the expression of hsa-miR-34a-5p and hsa-miR-375 in serum and saliva of young subjects (age 11 ± 3.467 years) with migraine without aura (MWA), while some underwent pharmacological...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679182/ https://www.ncbi.nlm.nih.gov/pubmed/31252698 http://dx.doi.org/10.3390/jcm8070928 |
_version_ | 1783441279185584128 |
---|---|
author | Gallelli, Luca Cione, Erika Peltrone, Fancesco Siviglia, Serena Verano, Antonio Chirchiglia, Domenico Zampogna, Stefania Guidetti, Vincenzo Sammartino, Luca Montana, Angelo Caroleo, Maria Cristina De Sarro, Giovambattista Di Mizio, Giulio |
author_facet | Gallelli, Luca Cione, Erika Peltrone, Fancesco Siviglia, Serena Verano, Antonio Chirchiglia, Domenico Zampogna, Stefania Guidetti, Vincenzo Sammartino, Luca Montana, Angelo Caroleo, Maria Cristina De Sarro, Giovambattista Di Mizio, Giulio |
author_sort | Gallelli, Luca |
collection | PubMed |
description | MicroRNAs (miRs) have emerged as biomarkers of migraine disease in both adults and children. In this study we evaluated the expression of hsa-miR-34a-5p and hsa-miR-375 in serum and saliva of young subjects (age 11 ± 3.467 years) with migraine without aura (MWA), while some underwent pharmacological treatment, and healthy young subjects were used as controls. miRs were determined using the qRT-PCR method, and gene targets of hsa-miR-34a-5p and hsa-miR-375 linked to pain-migraine were found by in silico analysis. qRT-PCR revealed comparable levels of hsa-miRs in both blood and saliva. Higher expression of hsa-miR-34a-5p and hsa-miR-375 was detected in saliva of untreated MWAs compared to healthy subjects (hsa-miR-34a-5p: p < 0.05; hsa-miR-375 p < 0.01). Furthermore, in MWA treated subjects, a significant decrease of hsa-miR-34a-5p and of hsa-miR-375 was documented in saliva and blood compared to MWA untreated ones. Altogether, these findings suggested thathsa-miR-34a-5p and hsa-miR-375 are expressed equally in blood and saliva and that they could be a useful biomarker of disease and of drug efficacy in patients with MWA. |
format | Online Article Text |
id | pubmed-6679182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66791822019-08-19 Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study Gallelli, Luca Cione, Erika Peltrone, Fancesco Siviglia, Serena Verano, Antonio Chirchiglia, Domenico Zampogna, Stefania Guidetti, Vincenzo Sammartino, Luca Montana, Angelo Caroleo, Maria Cristina De Sarro, Giovambattista Di Mizio, Giulio J Clin Med Article MicroRNAs (miRs) have emerged as biomarkers of migraine disease in both adults and children. In this study we evaluated the expression of hsa-miR-34a-5p and hsa-miR-375 in serum and saliva of young subjects (age 11 ± 3.467 years) with migraine without aura (MWA), while some underwent pharmacological treatment, and healthy young subjects were used as controls. miRs were determined using the qRT-PCR method, and gene targets of hsa-miR-34a-5p and hsa-miR-375 linked to pain-migraine were found by in silico analysis. qRT-PCR revealed comparable levels of hsa-miRs in both blood and saliva. Higher expression of hsa-miR-34a-5p and hsa-miR-375 was detected in saliva of untreated MWAs compared to healthy subjects (hsa-miR-34a-5p: p < 0.05; hsa-miR-375 p < 0.01). Furthermore, in MWA treated subjects, a significant decrease of hsa-miR-34a-5p and of hsa-miR-375 was documented in saliva and blood compared to MWA untreated ones. Altogether, these findings suggested thathsa-miR-34a-5p and hsa-miR-375 are expressed equally in blood and saliva and that they could be a useful biomarker of disease and of drug efficacy in patients with MWA. MDPI 2019-06-27 /pmc/articles/PMC6679182/ /pubmed/31252698 http://dx.doi.org/10.3390/jcm8070928 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gallelli, Luca Cione, Erika Peltrone, Fancesco Siviglia, Serena Verano, Antonio Chirchiglia, Domenico Zampogna, Stefania Guidetti, Vincenzo Sammartino, Luca Montana, Angelo Caroleo, Maria Cristina De Sarro, Giovambattista Di Mizio, Giulio Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
title | Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
title_full | Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
title_fullStr | Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
title_full_unstemmed | Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
title_short | Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study |
title_sort | hsa-mir-34a-5p and hsa-mir-375 as biomarkers for monitoring the effects of drug treatment for migraine pain in children and adolescents: a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679182/ https://www.ncbi.nlm.nih.gov/pubmed/31252698 http://dx.doi.org/10.3390/jcm8070928 |
work_keys_str_mv | AT gallelliluca hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT cioneerika hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT peltronefancesco hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT sivigliaserena hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT veranoantonio hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT chirchigliadomenico hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT zampognastefania hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT guidettivincenzo hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT sammartinoluca hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT montanaangelo hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT caroleomariacristina hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT desarrogiovambattista hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy AT dimiziogiulio hsamir34a5pandhsamir375asbiomarkersformonitoringtheeffectsofdrugtreatmentformigrainepaininchildrenandadolescentsapilotstudy |